Quick Menu

Upcoming Journals

British Journal of Pharmaceutical Research

British Journal of Pharmaceutical Research, ISSN: 2231-2919,Vol.: 1, Issue.: 1 (January-March)

Original Research Article

Evaluation of the Phytochemical Composition and Hypoglycaemic Activity of Methanolic Leaves Extract of Costus afer in Albino Rats

S. Momoh2*, O. W. Yusuf2, M. M. Adamu2, C .O. C. Agwu3 and F. O. Atanu1&2*


1School of Biological Sciences, University of Reading, United Kingdom (UK);
2Department of Biochemistry; 3Department of Biological Sciences, Faculty of Natural Sciences, Kogi State University, Anyigba, Nigeria.





Medicinal plants are reservoirs of natural products with anti-diabetic potentials. In the present study we screened Costus afer for the presence of plant products and to study the effects of the methanolic leaf extract of the plant on fasting blood glucose of normal rats. Adult male wistar strain albino rats were given graded doses (200-800mg/kg) of the methanolic leaf extract of Costus afer, standard hypoglycaemic drug glibenclamide or a combination of the two in the presence or absence of oral glucose feeding. Fasting blood glucose was monitored for 6 hours post administration of drugs. Phytochemical studies revealed relative amounts of alkaloids, flavanoids, tannins, phenols, glycosides and terpenoids. Costus afer showed significant hypoglycaemic effect (p<0.05) comparable with the standard drug. However, the plant extract did not reduce blood glucose in glucose fed rats. Also, a combination of plant extract and glibenclamide caused a significant reduction in fasting blood sugar of both glucose loaded and unloaded rats. The results validate the use of Costus afer as a hypoglycaemic plant in native medicine. These effects could be attributed to its phytochemical constituents. Costus afer could be a promising plant for the development of anti-diabetic drugs.




Keywords :

Hypoglycaemia, phytochemicals, diabetes mellitus, Costus afer;


Full Article - PDF    Page 1-8    Article Metrics


DOI : 10.9734/BJPR/2011/237

Review History    Comments

Search this site

Advanced Search

Announcement & News

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected  A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...


  • No Awards listed.

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2018, SCIENCEDOMAIN international. All rights reserved.